National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01BC05	HAXANIT	G	Gemcitabine (HCl) - 1g	1g	Injectable lyophilised powder	6,829,408 L.L
J05AF10	HEPCAVIR 1	G	Entecavir monohydrate - 1mg	1mg	Tablet, film coated	18,998,515 L.L
D04AA32	HISTERGAN	G	Diphenhydramine HCl - 2%	2%	Cream	546,944 L.L
D04AA32	HISTAFEN	G	Diphenhydramine HCl - 2%	2%	Solution	362,837 L.L
B01AB12	HIBOR	G	Bemiparin Sodium - 2,500IU	2,500IU	Injectable solution	704,173 L.L
J06BA02	HIZENTRA 1G	BioHuman	Immunoglobulin human - 1g/5ml	20%	Injectable solution	9,246,433 L.L
J06BA02	HIZENTRA 2G	BioHuman	Immunoglobulin human - 2g/10ml	20%	Injectable solution	17,658,835 L.L
J06BA02	HIZENTRA 4G	BioHuman	Immunoglobulin human - 4g/20ml	20%	Injectable solution	35,323,423 L.L
B05AA01	HUMAN ALBUMIN "OCTAPHARMA" 20%	BioHuman	Albumin human - 20%	20%	Injectable solution	4,863,366 L.L
B05AA01	HUMAN ALBUMIN 20% SOLUTION	BioHuman	Albumin human - 20%	20%	Injectable solution	4,177,896 L.L
B05AA01	HUMAN ALBUMIN BEHRING 20%, LOW SALT	BioHuman	Albumin human - 20%	20%	Injectable solution	4,177,896 L.L
B03XA01	HEMAX	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 20,000IU	20,000IU	Injectable freeze dried powder + diluent	5,438,531 L.L
L01BC05	HAXANIT	G	Gemcitabine (HCl) - 200mg	200mg	Injectable lyophilised powder	1,411,035 L.L
A02BC01	HYPOSEC	G	Omeprazole - 20mg	20mg	Capsule	659,827 L.L
A02BC01	HYPOSEC	G	Omeprazole - 20mg	20mg	Capsule	1,478,227 L.L
G04BE08	HEROX	G	Tadalafil - 20mg	20mg	Tablet, film coated	248,611 L.L
G04BE08	HEROX	G	Tadalafil - 20mg	20mg	Tablet, film coated	929,939 L.L
N05AD01	HALOPERIDOL	G	Haloperidol - 20mg	20mg	Tablet	339,160 L.L
M09AX01	HYALGAN	B	Hyaluronic acid (sodium) - 20mg/2ml	20mg/2ml	Injectable solution	3,407,985 L.L
L01FD01	HERCEPTIN	BioTech	Trastuzumab - 440mg	21mg/ml	Injectable concentrated powder for solution+diluent	166,423,476 L.L
L01FD01	HERCEPTIN	BioTech	Trastuzumab - 440mg	21mg/ml	Injectable concentrated powder for solution+diluent	166,423,476 L.L
B01AB01	HEPARINE SODIQUE PANPHARMA	G	Heparin sodium - 25,000IU/5ml	25,000IU/5ml	Injectable solution	6,134,641 L.L
B01AB01	HEPARINE MEDIS	G	Heparin sodium - 25,000UI/5ml	25,000UI/5ml	Injectable solution	6,853,597 L.L
C03DA04	HEPERONA 25	G	Eplerenone - 25mg	25mg	Tablet, coated	2,116,552 L.L
B02BB01	HAEMOCOMPLETTAN P	BioHuman	Fibrinogen, human - 2g	2g	Injectable powder for solution	73,094,026 L.L
N05AD01	HALOPERIDOL	G	Haloperidol - 2mg	2mg	Tablet	252,130 L.L
B01AB12	HIBOR	G	Bemiparin Sodium - 3,500IU	3,500IU	Injectable solution	1,029,383 L.L
B02BX06	HEMLIBRA	BioTech	Emicizumab - 30mg/ml	30mg/ml	Injectable solution	224,585,721 L.L
B02BX06	HEMLIBRA	BioTech	Emicizumab - 30mg/ml	30mg/ml	Injectable solution	L.L
R05CA12	HEDERAL	G	Dried Ivy leaf extract - 37mg/5ml	37mg/5ml	Syrup	309,084 L.L

National Cancer Registry (NCR)